Aristotle University Of Thessaloniki (AUTH)
Αξιολόγηση ορολογικών, απεικονιστικών παραμέτρων και προγνωστικών δεικτών ίνωσης σε ασθενείς με χρόνιες φλεγμονώδεις ηπατικές παθήσεις
Abstract
dc:descriptionBACKGROUND: Assessment of liver fibrosis is a significant parameter for the overall clinical assessment of liver diseases given that the development of histologically proven liver fibrosis determines prognosis in diseases concerned. AIM: The assessment of liver fibrosis in chronic inflammatory liver diseases through non invasive serological markers and imaging techniques of liver fibrosis and the comparison of the results with the histological evaluation of liver biopsy specimens in order to find the most accurate non invasive method or the most efficient combination of them.PATIENTS-METHODS: 80 patients with chronic liver diseases were included in this study. In all patients blood serum was obtained, body and demographic characteristics were recorded, transient elastography (TE) was performed and finally liver specimen was obtained through liver biopsy. In addition, in 77 patients FΤ was done and 18 NAFLD patients underwent DWI.RESULTS: The diagnostic accuracy of TE, APRI and FT in patients with CHB for fibrosis stage F≥2 was 0,75, 0,69 and 0,83 respectively and for fibrosis stage F≥3 was 0,84, 0,74 and 0,6 respectively. The diagnostic accuracy of TE, APRI and FT in patients with NAFLDΗ for fibrosis stage F≥2 was 0,95, 0,90 and 0,86 respectively and for fibrosis stage F≥3 was 0,94, 0,86 και 0,89 respectively. The diagnostic accuracy of DWI at b value 0-1000 s/mm2 in NAFLD patients for fibrosis stage F≥2 και F≥3 was 0,88 and 0,93 respectively. Liver biopsy could be avoided in 90% of NAFLD patients when TE and FT were combined and both methods agreed (49% of patients). In all methods overlap was observed in intermediate fibrosis stages. Also in 11,4% of NAFLD patients and 12,5% of CHB patients, TE measurement could not be acquired due to technical restrictions. Especially for NAFLD patients no valid measurement could be achieved in 9,1% mainly in patients with severe fibrosis and cirrhosis. Finally, ALT levels more than 1,5x UNL seem to affect the diagnostic accuracy of TE.CONCLUSIONS: The diagnostic accuracy of all non invasive methods analyzed was overall superior in NAFLD patients compared to CHB patients. In all methods significant overlap was observed in intermediate fibrosis stages. TE in patients with CHB should possibly be performed after antiviral treatment because of its affection by necroinflammatory activity. IQR/M >30% was the main reason of TE invalid measurements in CHB patients whereas inability to obtain at least one valid measurement was the main reason of TE invalid measurements in NAFLD patients, especially in patients with severe fibrosis and cirrhosis. In 90% of NAFLD patients liver biopsy could be avoided when TE and FT were combined and both methods agreed. DWI performed in 3 Tesla scanners seems to provide superior diagnostic accuracy for liver fibrosis evaluation compared to 1,5 Tesla scanners especially when it is performed at b value 0-1000 s/mm2.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Papalavrentios, Lavrentios
- Παπαλαυρέντιος, Λαυρέντιος
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/34573